Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 244
Filter
1.
Acta Neurologica Taiwanica ; 31(4):167-170, 2022.
Article in English | Scopus | ID: covidwho-1877042

ABSTRACT

Purpose: To highlight the factors leading to the delayed diagnosis of basilar artery occlusion and poor outcome in the postpartum period during the prevailing Corona Virus Disease-2019 (COVID-19) pandemic. Case report: We here report a case of a 34-year female who presented with a headache localized to the occipital region after cesarean section under spinal anesthesia. Her headache severity increased over time, and she developed a generalized seizure episode and became unconscious. Subsequently, basilar artery thrombosis was diagnosed. Despite all efforts, she succumbed to death. We believe that we might have saved the patient's life if we could have made the diagnosis beforehand. Conclusion: We recommend that unless shown otherwise, postpartum headache and neck discomfort, even in individuals with no known risk factors, should have a low index of suspicion, early diagnosis using non-invasive radiological study such MRI to rule out this uncommon but deadly illness quickly. © 2022, Neurological Society R.O.C (Taiwan). All rights reserved.

2.
Journal of Family Medicine and Primary Care ; 11(5):1820-1825, 2022.
Article in English | GIM | ID: covidwho-1875928

ABSTRACT

Aim: This study aims to describe the clinical characteristics, maternal and neonatal outcome of pregnancies complicated with COVID-19 infection.

3.
Emergency Medicine Journal ; 39(6):483-484, 2022.
Article in English | ProQuest Central | ID: covidwho-1874627

ABSTRACT

Editor’s note: EMJ has partnered with the journals of multiple international emergency medicine societies to share from each a highlighted research study, as selected by their editors. This edition will feature an from each publication.

4.
Revista Espanola de Salud Publica ; 95(e202108105), 2021.
Article in Spanish | CAB Abstracts | ID: covidwho-1870917

ABSTRACT

Background: The COVID-19 pandemic caused that the Health Department of the Autonomous Region of Madrid redirected the Obstetrics, Gynecology and Neonatology emergency care. On March 24th 2020, the HULP launched a program of postpartum early discharge and home visit. The objective of this work was to detect if the care strategy "Voluntary early discharge and home visit by the midwife (2nd year EIR)" applied by the HULP during the COVID-19 pandemic had any adverse effect on the woman and/or the newborn.

5.
Front Psychiatry ; 13: 735582, 2022.
Article in English | MEDLINE | ID: covidwho-1869420

ABSTRACT

The necessity of hybrid and more accessible options for perinatal mood and anxiety disorders (PMADs) has taken on increased urgency in the wake of the COVID-19 pandemic and its lasting impacts. In the New Family Wellness Project (NFWP), participants engage in a hybrid in-person and teletherapy six-session intervention for new parents early in their postpartum period. This small, phase 1 clinical research examined early outcomes of the NFWP's cognitive behavioral intervention on adverse mental health outcomes (i.e., perinatal depression and anxiety, overall mental illness symptoms) and adaptive outcomes and protective factors (i.e., relational health, social support, flourishing, self-efficacy). Despite a small sample size (N = 12), paired t-tests yielded significant effects for improvements in mental health symptoms at posttest, as well as marginally significant improvements in postpartum anxiety and self-efficacy. Findings suggest the brief, partner-inclusive, hybrid intervention shows promise for further study. Lessons learned from this small phase 1 clinical study and recommendations for revising the intervention prior to future trials are discussed.

6.
J Matern Fetal Neonatal Med ; : 1-7, 2022 Jun 01.
Article in English | MEDLINE | ID: covidwho-1868190

ABSTRACT

OBJECTIVE: To investigate the association between health literacy and COVID-19 prevention behaviors among pregnant and postpartum women in Japan. METHODS: In this cross-sectional, web-based, self-reported questionnaire survey, we investigated the association between health literacy and COVID-19 prevention behaviors among pregnant and postpartum women in Japan. A multivariable logistic regression analysis was performed to evaluate the association with adjustment for socioeconomic characteristics. RESULTS: There were 926 respondents, comprising 368 pregnant and 558 postpartum women. Women with high health literacy scores accounted for 42% of the respondents. This group had a significantly higher proportion of actively adopting preventive behaviors than the low health literacy group (33.5 vs. 25.4%, p = .008). The multivariable logistic regression analysis showed high health literacy was significantly associated with high preventive behaviors scores compared to low health literacy (adjusted odds ratio, 1.66; 95% confidence interval, 1.22-2.27). CONCLUSION: Higher health literacy was significantly associated with a higher proportion of COVID-19 prevention behaviors among women who are pregnant or postpartum.

7.
Folia Medica ; 64(1):21-26, 2022.
Article in English | ProQuest Central | ID: covidwho-1862977

ABSTRACT

Страх перед COVID-19, особенно среди уязвимых групп, таких как беременные женщины, вызвал чрезмерную озабочен- ность, что привело к неожиданным психоэмоциональным последствиям и необходимости обобщить последние данные по этой теме. Поэтому мы провели описательный обзор доступной литературы, синтезируя данные из доступных баз данных. По результатам данного опроса, беременные женщины во время пандемии COVID-19 были более тревожными и депрессив- ными в основном из-за страха заразиться вирусом, ограничительных мер и опасений за здоровье своих будущих детей. Повышенный уровень стресса у беременных в связи с пандемией может быть фактором риска усложнения физического здо- ровья. Поэтому среди беременных женщин следует поощрять стратегии, включающие расслабление, осторожность, принятие и позитивное отношение к COVID-19.Alternate :Fear of COVID-19, especially in vulnerable groups such as pregnant women, created excessive concern leading to unexpected psychoemotional consequences and a need to summarize the most recent knowledge about this topic. Therefore, we conducted a narrative review of the relevant literature, synthesizing data from available databases. According to the findings of this review, pregnant women during COVID-19 pandemic were more anxious and depressed mainly due to the fear of contacting the virus, restricting measures, and concerns about the health of their unborn children. The elevated stress levels in pregnant women due to the pandemic could represent risk factors for physical health complications. Thus, strategies including relaxation, mindfulness, acceptance, and positive attitude to COVID-19 should be promoted for pregnant women.

8.
British Journal of Haematology ; 197(SUPPL 1):214-215, 2022.
Article in English | EMBASE | ID: covidwho-1861246

ABSTRACT

The risk of venous thromboembolism (VTE) increases by 10% in pregnancy to around 1/1000 and is a leading cause of death in pregnant women. Low molecular weight heparins (LMWHs) are the anticoagulant of choice for treatment of acute VTE during pregnancy. The initial dose of LMWH is weight based but currently there is lack of evidence supporting routine Anti-Xa monitoring during pregnancy and LMWH dose adjustments based on Anti-Xa levels. We conducted a retrospective audit of pregnant patients receiving therapeutic dose LMWH between October 2020 and October 2021 in a tertiary referral centre. The aim of this audit was to review LMWH dosages required in pregnancy to achieve peak Anti-Xa levels relative to weight-based and report maternal thrombotic or bleeding outcomes based on dose adjustments. A total of 21 pregnant patients were included who required therapeutic LMWH (Tinzaparin) during pregnancy. Of these, 10 (48%) had an acute VTE in the index pregnancy;one (4%) had recurrence of DVT despite weight adjusted LMWH. Ten (48%) were on long-term anticoagulation for a prior VTE including two with antithrombin deficiency and one with JAK 2 positive myeloproliferative disorder. They were all changed to LMWH during pregnancy. The site of acute VTE in index pregnancy (11) included: five (45%) deep vein thrombosis (DVT), three (28%) pulmonary emboli (PE), two (18%) had thromboses at an unusual site, and one patient (9%) had a superficial thrombophlebitis with gestational age range 7-40 weeks. Majority of pregnant patients (18/21;86%) had at least one peak Anti-Xa measured, and 12 (67%) patients had dose of LMWH increased at least once to achieve a target peak Anti-Xa level of 0.5-0.7 IU/ml. Five required two dose adjustments, and one required three dose adjustments. Nineteen patients have delivered and two have ongoing pregnancy. Twelve patients had spontaneous vaginal delivery, three assisted vaginal delivery and four had caesarean section for obstetric reasons. No patients had a recurrent thrombosis while on therapeutic dose LMWH and with dose adjustments as per peak anti-Xa level. One patient who presented with an acute DVT at 40 weeks of gestational age (GA) was managed with twice daily therapeutic dose Tinzaparin and insertion of an inferior vena cava (IVC) filter for anticoagulation interruption around delivery. The last dose Tinzaparin was 12 h prior to emergency Caesarean Section. She had postpartum haemorrhage with an estimated blood loss of 1800 ml but did not require blood product support and there was no evidence of progression of her symptoms of VTE or bleeding postoperatively when anticoagulation was resumed. Of note, six patients (29%) had a BMI >30 with five (83%) needing at least one adjustment of LMWH dose based on Anti-Xa levels and two (33%) needing > 2 dose increments with LMWH based on Anti-Xa monitoring. One patient had recurrence of PE on weight based LMWH dose with no recurrence of symptoms when the LMWH dose was adjusted to peak Anti-Xa level. None of the patients developed SARS-CoV-2 infection in the reported cohort. Fourteen (67%) pf pregnant had received their COVID-19 vaccination during this period . None of the thrombotic episodes were associated with COVID-19 vaccination. Although this audit study has limitations due to small patient numbers there was no evidence of increase in bleeding or thrombotic risk with ongoing anticoagulation with Anti-Xa monitoring during pregnancy..

10.
Front Public Health ; 10: 841832, 2022.
Article in English | MEDLINE | ID: covidwho-1855462

ABSTRACT

Under longstanding federal law, pregnancy-related Medicaid coverage is only guaranteed through 60-days postpartum, at which point many women become uninsured. Barriers to care, including lack of insurance, contribute to maternal mortality and morbidity. Leveraging the Families First Coronavirus Response Act, a federal law requiring that states provide continuous coverage to Medicaid enrollees during the COVID-19 pandemic as a condition of receiving enhanced federal financial support, we examine whether postpartum women seek additional care, and what types of care they use, with extended coverage. We analyze claims from the Parkland Community Health Plan (a Texas Medicaid Health Maintenance Organization) before and after implementation of the pandemic-related Medicaid extension. We find that after implementation of the coverage extension, women used twice as many postpartum services, 2 × to 10 × as many preventive, contraceptive, and mental/behavioral health services, and 37% fewer services related to short interval pregnancies within the first-year postpartum. Our findings provide timely insights for state legislators, Medicaid agencies, and members of Congress working to improve maternal health outcomes. We add empirical evidence to support broad extension of Medicaid coverage throughout the first-year postpartum.


Subject(s)
COVID-19 , Medicaid , Female , Health Maintenance Organizations , Health Services Accessibility , Humans , Insurance Coverage , Pandemics , Postpartum Period , Pregnancy , Texas , United States
11.
Annals of Indian Psychiatry ; 6(1):57-62, 2022.
Article in English | Web of Science | ID: covidwho-1855975

ABSTRACT

Aims: We aimed to study the prevalence of mental health problems in postpartum women during coronavirus disease 2019 (COVID-19) pandemic and to evaluate various parameters affecting it. Methods: Data were collected from May 15, 2020, to October 15, 2020, and during this period, 311 postpartum women were enrolled in the study. Sociodemographic data and obstetric-related information and Depression, Anxiety, and Stress Scale-21 were administered. Data were analyzed for the prevalence of depression, anxiety, and stress among postpartum women and various factors that affect mental health. Results: Postpartum women showed a higher prevalence of depression (38%), anxiety (42%), and stress (21%). It was more in rural background women, single mother, having 4-5 children, and from higher socioeconomic (lower socioeconomic status) background. Conclusion: This study assessed the prevalence of mental health problems in postpartum women and highlighted the high prevalence rates of anxiety, depression, and stress among this population.

12.
Journal of Cardiac Critical Care ; 5(3):265-267, 2021.
Article in English | EMBASE | ID: covidwho-1852586

ABSTRACT

Coronavirus disease (COVID) pneumonia in the recent times has shown us the importance of prone positioning during the management of moderate to severe hypoxia. In fact, we have rediscovered the benefits of this positional maneuver in coping with the oxygen crisis during the second wave of this dreaded pandemic. While we (the clinicians) derive benefits of this postural therapy for treating our patients, it is imperative for us to know the underlying mechanisms behind improvement in oxygenation in mild to moderate cases of COVID pneumonia. In this brief communication, we try to decipher the miracles of this great life-saver.

13.
J Obstet Gynecol Neonatal Nurs ; 2022 May 20.
Article in English | MEDLINE | ID: covidwho-1851611

ABSTRACT

OBJECTIVE: To evaluate the relationship between maternal COVID-19 infection and the odds of in-hospital exclusive breastfeeding for term newborns. DESIGN: Retrospective descriptive quantitative. SETTING: A large, urban hospital with more than 6,000 births annually. SAMPLE: Term newborns born between March 1, 2020, and March 31, 2021 (N = 6,151). METHODS: We retrospectively extracted data from electronic health records to evaluate the relationship of maternal COVID-19 infection with the odds of in-hospital exclusive breastfeeding using univariate analysis and logistic regression models. The covariates included insurance type, race/ethnicity, glucose gel administration, length of stay, newborn gestational age, newborn birth weight, and maternal COVID-19 infection. RESULTS: Maternal COVID-19 infection was not significantly related to the odds of in-hospital exclusive breastfeeding (p = .138) after adjustment for covariates in the logistic regression model. However, when newborns who received pasteurized donor human milk supplementation were excluded from the logistic regression model, maternal COVID-19 infection significantly decreased the odds of in-hospital exclusive breastfeeding (p = .043). CONCLUSION: Maternal COVID-19 infection was not significantly related to the odds of in-hospital exclusive breastfeeding when newborns received donor human milk supplementation. Access to donor human milk for supplementation for term newborns may protect the odds of in-hospital exclusive breastfeeding.

14.
Ginecologia y Obstetricia de Mexico ; 90(1):8-20, 2022.
Article in Spanish | Scopus | ID: covidwho-1848036

ABSTRACT

OBJECTIVE: To determine the prevalence of postpartum depression during the CO-VID-19 pandemic and the factors associated with infection. MATERIALS AND METHODS: Observational, analytical and cross-sectional study and carried out in patients attended at Hospital Dr. José Eleuterio González from February to May 2021 after 24 to 48 hours of puerperium. The Edinburgh Scale was applied in writing. Positive screening was considered for postpartum depression with a score greater than 10. Two groups were compared: patients with a history of positive COVID-19 test and those without. Patients with chronic degenerative diseases, rheumatic diseases, pregnancy with death or malformations were excluded. RESULTS: A total of 116 patients were studied: 56 positive for COVID-19 and 60 with no history of disease. The prevalence of depression was 15%. A history of COVID-19 added 2 positive points to the Edinburgh Scale, although it did not result in a factor associated with depression. Factors associated with a score greater than 10 were: junior high and high school education, and male sex of the newborn. Newborn sex resulted in similar percentages in both groups. CONCLUSIONS: COVID-19 contingency and history of SARS CoV-2 infection showed no association with depression. Higher schooling and male birth were observed in women with Edinburgh Scale score greater than 10. © 2022 Asociacion Mexicana de Ginecologia y Obstetricia. All rights reserved.

15.
BMC Pregnancy Childbirth ; 22(1): 402, 2022 May 12.
Article in English | MEDLINE | ID: covidwho-1846810

ABSTRACT

BACKGROUND: Pregnant women were excluded from investigational trials of COVID-19 vaccines. Limited data are available to inform pregnant and postpartum women on their decisions to receive a COVID-19 vaccine. METHODS: The goal of this observational, prospective cohort study is to evaluate the immunogenicity and safety of various Emergency Use Authorization (EUA) or licensed COVID-19 vaccines administered to pregnant or lactating women and describe the transplacental antibody transfer and kinetics of antibodies in mothers and infants. The study is adaptive, allowing additional groups to be added as new vaccines or vaccine regimens are authorized. Up to 20 clinical research institutions in the United States (U.S.) will be included. Approximately 200 pregnant women and 65 postpartum women will be enrolled per EUA or licensed COVID-19 vaccine formulation in the U.S. This study will include pregnant and postpartum women of all ages with and without chronic medical conditions. Their infants will be enrolled and followed beginning at birth in the pregnant cohort and beginning at the earliest possible time point in the postpartum cohort. Blood samples will be collected for immunogenicity outcomes and pregnancy and birth outcomes assessed among women and infants. Primary analyses will be descriptive and done by vaccine type and/or platform. DISCUSSION: Given the long-standing and legitimate challenges of enrolling pregnant individuals into clinical trials early in the vaccine development pipeline, this study protocol describes our current study and provides a template to inform the collection of data for pregnant individuals receiving COVID-19 or other vaccines. TRIAL REGISTRATION: NCT05031468 .


Subject(s)
COVID-19 Vaccines , COVID-19 , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Female , Humans , Infant , Infant, Newborn , Lactation , Multicenter Studies as Topic , Observational Studies as Topic , Pregnancy , Prospective Studies
16.
BMJ Open ; 11(8), 2021.
Article in English | ProQuest Central | ID: covidwho-1842904

ABSTRACT

IntroductionThe COVID-19 pandemic has caused unprecedented disruptions around the world. Adding to the existing stress surrounding pregnancy and childbirth, the threat of infection and social isolation policies may negatively impact pregnant women and new mothers. Literature on the effect of COVID-19 on fear during pregnancy and childbirth experience is limited. As the COVID-19 pandemic continues to affect the global population, it is important to understand how it has impacted pregnant women and new mothers’ experiences worldwide to inform perinatal care and interventions.Methods and analysisThis multicountry study involving China and Canada targets to recruit 1000 pregnant women and new mothers who gave birth since 2020 in each participating country. Participants will be recruited online in the local language through mothers’ groups, antenatal and postnatal clinics and hospital wards. All questionnaires will be completed online. Participants’ level of fear, depression and childbirth experience will be assessed along with other sociodemographic, medical and COVID-related measures. Regression models will be used to compare the outcomes among the participating countries.Ethics and disseminationThe study has been reviewed and approved by the institutional review boards of the participating countries. Findings will be disseminated in peer-reviewed journals and academic conferences. Results from this study may guide the formulation of future health guidelines and policies in the face of a pandemic.

17.
JAMA Psychiatry ; 78(11):1285, 2021.
Article in English | APA PsycInfo | ID: covidwho-1837897

ABSTRACT

Reports an error in "Effect of online 1-day cognitive behavioral therapy-based workshops plus usual care vs usual care alone for postpartum depression: A randomized clinical trial" by Ryan J. Van Lieshout, Haley Layton, Calan D. Savoy, June S. L. Brown, Mark A. Ferro, David L. Streiner, Peter J. Bieling, Andrea Feller and Steven Hanna (JAMA Psychiatry, 2021[Nov], Vol 78[11], 1200-1207). In the originally published article, 2 pieces of data were incorrectly presented in the third paragraph of the Results section, where the denominator and percentage in the first sentence were incorrect. That sentence should have appeared as follows: "The intervention was well tolerated, with 10 of 161 participants in the experimental group (6%) expressing a preference that it be delivered differently (eg, in half-days)." This article was corrected online. (The of the original article appeared in record 2022-41504-002). Importance: Postpartum depression (PPD) affects as many as 20% of mothers, yet just 1 in 10 of these women receives evidence-based treatment. The COVID-19 pandemic has increased PPD risk, reduced treatment access, and shifted preferences toward virtual care. Objective: To determine whether an online 1-day cognitive behavioral therapy (CBT)-based workshop added to treatment as usual improves PPD, anxiety, social support, mother-infant relationship quality, and infant temperament more than treatment as usual alone. Design, setting, and participants: This randomized clinical trial included 403 women with PPD who were recruited across Ontario, Canada, during the COVID-19 pandemic (April 20 to October 4, 2020). Women with Edinburgh Postnatal Depression Scale (EPDS) scores of at least 10 who were 18 years or older and had an infant younger than 12 months were eligible. Interventions: Women were randomly assigned to receive a live, interactive online 1-day CBT-based workshop delivered by a registered psychotherapist, psychiatrist, or clinical psychology graduate student in addition to treatment as usual (n = 202) or to receive treatment as usual and wait-listed to receive the workshop 12 weeks later (n = 201). Main outcomes and measures: The primary outcome was change in PPD (EPDS scores) in experimental and wait list control groups 12 weeks after baseline. Secondary outcomes included maternal anxiety (7-item Generalized Anxiety Disorder Questionnaire [GAD-7]), social support (Social Provisions Scale), quality of the mother-infant relationship (Postpartum Bonding Questionnaire), and infant temperament (Infant Behavior Questionnaire-Revised Very Short Form). Results: Participants all identified as women with a mean (SD) age of 31.8 (4.4) years. The workshop led to significant mean (SD) reductions in EPDS scores (from 16.47 [4.41] to 11.65 [4.83];B = -4.82;P < .001) and was associated with a higher odds of exhibiting a clinically significant decrease in EPDS scores (odds ratio, 4.15;95% CI, 2.66-6.46). The mean (SD) GAD-7 scores decreased from 12.41 (5.12) to 7.97 (5.54) after the workshop (B = -4.44;95% CI, -5.47 to -3.38;P < .001) and participants were more likely to experience a clinically significant change (odds ratio, 3.09;95% CI, 1.99-4.81). Mothers also reported improvements in bonding (B = -3.22;95% CI, -4.72 to -1.71;P < .001), infant-focused anxiety (B = -1.64;95% CI, -2.25 to 1.00;P < .001), social support (B = 3.31;95% CI, 1.04 to 5.57;P < .001), and positive affectivity/surgency in infants (B = 0.31;95% CI, 0.05 to 0.56;P < .001). Conclusions and relevance: In this randomized clinical trial, an online 1-day CBT-based workshop for PPD provides an effective, brief option for mothers, reducing PPD and anxiety as well as improving social support, the mother-infant relationship, and positive affectivity/surgency in offspring. Trial registration: ClinicalTrials.gov Identifier: NCT04485000. (PsycInfo Database Record (c) 2022 APA, all rights reserved)

18.
Eur J Midwifery ; 6: 23, 2022.
Article in English | MEDLINE | ID: covidwho-1836125

ABSTRACT

INTRODUCTION: A significant proportion of pregnant women and women in the early postpartum period suffer from mental health problems. The COVID-19 pandemic represents a unique stressor during this period and many studies across the world have shown elevated rates of postpartum depression (PPD). METHODS: In this multicenter two-phase observational prospective cohort study, we aim to assess the prevalence of anxiety prior to labor (Generalized Anxiety Disorder-7), as well as PPD at 6-8 weeks postpartum using the Edinburgh Postnatal Depression Scale (EPDS). RESULTS: Of the 330 women analyzed, 13.2% reported symptoms of depression using EPDS cut-off score ≥13. High antenatal levels of anxiety (24.8% scored ≥10 in GAD-7) were documented. A significant proportion of postpartum women reported a decrease in willingness to attend antenatal education courses (36%) and fewer antenatal visits to their obstetrician (34%) due to pandemic. Higher antenatal anxiety increased the odds of being depressed at 6-8 weeks postpartum (EPDS ≥13). CONCLUSIONS: Compared to reported prevalence of PPD from previous studies before the COVID-19 era in Greece, we did not find elevated rates during the first wave of the pandemic. High anxiety levels were observed indicating that there is a need for close monitoring in pregnancy during the pandemic and anxiety screening to identify women who need support in the pandemic era. A well-planned maternity program should be employed by all the associated care providers to maintain the proper antenatal care adjusted to the pandemic strains as well as a follow-up after labor.

19.
BMC Nurs ; 21(1): 99, 2022 Apr 27.
Article in English | MEDLINE | ID: covidwho-1817218

ABSTRACT

BACKGROUND: The global COVID-19 pandemic has forced the health care sector to make wide-ranging changes to protect patients as well as providers from the risk of infection. Many of these changes are likely to have greatest impact in contexts of care that employ family-centered care (FCC) models, including perinatal and maternity care. Research conducted in perinatal care settings during the pandemic has shown that some of these restrictions have negatively impacted patient and family experiences and outcomes, while others have been perceived as beneficial. The present qualitative study aimed to understand what changes have occurred in postpartum nursing practice during the pandemic, and how these changes have affected nurses, women and families during their stay in the hospital following a new birth. METHODS: Structured interviews were completed with 20 postpartum nurses from five hospitals across Texas. The interview protocol was designed to elicit information about changes to hospital policies in postpartum units during the pandemic, nurses' attitudes about these changes, perceived benefits and challenges for performance of their duties, and perceived effects on patients and their families. Nurses were recruited for the study using a purposive sampling approach. Interviews were conducted by video conference using Zoom and lasted approximately 30 to 45 min. Data were analyzed using a qualitative descriptive approach. RESULTS: Participants reported that their hospitals placed restrictions on the number and mobility of support persons allowed to stay with the mother in the unit and prohibited all other visitation. Some challenges of these policies included reduced opportunities for hands-on learning and an increased number of patients opting for early discharge. Perceived benefits for patient education and outcomes included improved frequency and effectiveness of nurse-family communication, increased father involvement, and greater opportunities for maternal rest, breastfeeding, skin-to-skin care and family bonding. CONCLUSIONS: Study findings suggest that some limitations on postpartum hospital visitation may achieve important, family-centered goals. Protected time for family-bonding, maternal rest, breastfeeding, father involvement and individualized education are critical to quality FCC. Research must examine which visitation policies maximize these benefits while preserving patient access to family and social support.

20.
Physiother Theory Pract ; : 1-11, 2022 Apr 28.
Article in English | MEDLINE | ID: covidwho-1815803

ABSTRACT

BACKGROUND: Persistent pregnancy-related pelvic girdle pain (PGP) and the resulting consequences may considerably influence a woman's quality of life. The complexity of this condition requires a whole-person centered approach. In response to COVID-19 outbreak, telerehabilitation has emerged as a promising alternative to traditional in-person visits. PURPOSE: The aim of this report was to present the potential of telerehabilitation for persistent postpartum PGP within the biopsychosocial framework. CASE DESCRIPTION: A 26-year-old female presented with persistent pregnancy-related PGP of 8 months duration after her first vaginal delivery. The video-consults were performed using telerehabilitation platform. The patient received six telerehabilitation consults of 45 min duration over five weeks. Assessment of physical and psychosocial factors, cognitively focused strategies including pain neurophysiology education, sensory-motor remapping exercises, and graded increase of activity were administered. Rehabilitation was divided into the following phases: assessment, desensitization, graded exposure, and supported independence. OUTCOMES: The Pelvic Girdle Questionnaire (PGQ) score was significantly reduced from 72.2 during the assessment to 15.3 at discharge. This change was significantly more substantial than the minimal clinically important change estimated for the PGQ. CONCLUSION: Physiotherapists can utilize telerehabilitation to assist them with enacting appropriate care measures for persistent PGP within a biopsychosocial framework.

SELECTION OF CITATIONS
SEARCH DETAIL